HD-OPM Archive
Topics › Statins

Nocebo effect explained about 90% of symptoms in patients who quit statins (SAMSON trial)

Louis Nervegna · Apr 15, 2024 · ♥ 9 reactions · 9 comments · original Facebook post
Statins
AI summary & key facts

Louis highlights the SAMSON n-of-1 study of people who had stopped statins for side effects. Symptom intensity was similar on placebo and atorvastatin, and both were significantly greater than during a no-tablet period, suggesting most symptoms were due to a nocebo effect. He calls it one of the most eye-opening studies he has read.

The nocebo effect explains 90% of symptoms in patients who quit statins because of side effects.

This was one of the most eye opening studies that I ever read. The power of the mind in immense. It’s hard to argue with these results given the rigorous way that the study was designed and conducted.

#noceboHD #statinsHD #samsonHD

ccjm.org‘Nocebo’ effect explains 90% of symptoms in patients who quit statins because of side effects | Cleveland Clinic Journal of MedicinePresenters: James Philip Howard, PhD, MB and Francine K. Welty, MD, PhD An “n-of-1” study of patients who discontinued statin therapy because of side effects reveals similar intensity of symptoms between placebo and atorvastatin, both of which were significantly greater than symptom severity experienced during a no-tablet period. The findings from the…ccjm.org

Research cited

← newer: Rapamycin did not slow atherosclerosis in marmosets, and whyolder: PCSK9 inhibitors like Repatha have real side effects and a s →